Ageing alters the severity of Sunitinib-induced cardiotoxicity: Investigating the mitogen activated kinase kinase 7 pathway association
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 411, 49-59
Abstract
No abstract availableKeywords
Funding Information
- Centre for Sport, Exercise and Life Sciences within the Faculty of Health & Life Sciences at Coventry University
This publication has 60 references indexed in Scilit:
- Safety and activity of sunitinib in elderly patients (≥70 years) with metastatic renal cell carcinoma: a multicenter studyAnnals of Oncology, 2012
- Aging-Associated Cardiovascular Changes and Their Relationship to Heart FailureHeart Failure Clinics, 2012
- Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterationsToxicology and Applied Pharmacology, 2011
- Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group StudyClinical Cancer Research, 2011
- Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cellsToxicology and Applied Pharmacology, 2010
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell CarcinomaDigestive Diseases and Sciences, 2009
- Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer CellsJournal of Biological Chemistry, 2009
- An Analysis of Human MicroRNA and Disease AssociationsPLOS ONE, 2008
- GADD45B inhibits MKK7-induced cardiac hypertrophy and the polymorphisms of GADD45B is associated with inter-ventricular septum hypertrophyBiochemical and Biophysical Research Communications, 2008
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007